Salinomycin (SAL), a monocarboxylic polyether antibiotic isolated from Streptomyces albus, modulates various cellular responses, including proliferation, apoptosis, and inflammation. However, the effect of SAL on the dedifferentiation of chondrocytes remains unclear. Thus, we investigated the effects and regulatory mechanisms of SAL on the dedifferentiation of rabbit articular chondrocytes. Our results indicate that SAL-induced a loss of type II collagen and decreased sulfated proteoglycan levels in a doseand time-dependent manner, as assessed by western blot analysis and alcian blue staining. Consistent with dedifferentiation, we found that type II collagen expression was decreased and type I collagen and SOX-9 expression was increased using RT-PCR. Immunohistochemical and immunofluorescence staining also indicated dedifferentiation of chondrocytes. SAL treatment activated the mitogen-activated protein (MAP) kinase signaling pathway. Among the MAP kinases, extracellular signal-regulated kinase (ERK) was phosphorylated and translocated into the nucleus from the cytosol following SAL treatment. Inhibition of ERK with PD98059 (PD) rescued the SAL-induced decrease in type II collagen, increase in type I collagen, and reduction in sulfated proteoglycan. Our findings suggest that SAL induces dedifferentiation via the ERK pathway in rabbit articular chondrocytes.
Introduction
Osteoarthritis (OA) is one of the most common chronic diseases and a major cause of disability among the elderly (1) . With an aging worldwide population, the incidence of OA is rapidly increasing, and it is anticipated that OA will become the fourth leading cause of disability in the coming decades (2) . However, despite the growing number of OA patients, the causes of this disorder have not been fully elucidated. OA is characterized by progressive degradation of articular cartilage and insufficient synthesis of cartilage-specific ECM because of a loss of chondrocyte phenotype (dedifferentiation), and chondrocyte apoptosis (3) . Differentiated chondrocytes, which are the only cells found in normal mature cartilage, synthesize sufficient amounts of cartilage-specific extracellular matrix (ECM) to maintain matrix integrity (1) . Further, differentiated articular chondrocytes are distinguished by their ability to synthesize cartilage-specific ECM molecules, type II collagen, and sulfated-proteoglycan. Dedifferentiation of these chondrocytes results in loss of type II collagen expression and an increase in type I and type III collagen. Importantly, modulation of matrix metalloproteinases (MMPs) and increased numbers of apoptotic cells are correlated with the degradation of cartilage matrix (4e6). Thus, understanding the mechanisms by which ECM synthesis is lost during OA may be useful for developing novel therapeutics.
Interestingly, previous work has shown that pro-inflammatory cytokines, such as interleukin (IL)-1b and tumor necrosis factor (TNF)-a, play a crucial role in biochemical alterations of cartilage and chondrocytes (7) . Nitric oxide (NO) produced by IL-1b-stimulated chondrocytes causes dedifferentiation through the activation and expression of MMPs, thereby inhibiting proteoglycan synthesis and type II collagen expression. It was further shown that NO-induced chondrocyte dedifferentiation was regulated by mitogen-activated protein (MAP) kinases such as extracellular signal-regulated protein (ERK) and p38 kinase (8, 9) .
Various stimuli can activate the Raf/MEK/ERK signaling pathways, including mitogen and growth factor stimulation (10) . This pathway is highly specific, as Raf can only activate MEK, and MEK can only activate ERK (11) . ERK is primarily localized in the cytoplasm of resting cells, and translocates to the nucleus following acute stimulation (12, 13) . Thus, it is possible that extracellular stimulation of the Raf/MEK/ERK could contribute to OA through chondrocyte dedifferentiation.
Salinomycin (SAL) is a potassium ionophore isolated from Streptomyces albus that was originally used an antibiotic (14) . In addition to other natural ionophores, it is used commercially as a coccidiostat in poultry and to promote growth in cattle. Recently, it was shown that SAL can regulate apoptosis, proliferation, and differentiation in diverse cell types (15, 16) . Not surprisingly, SAL, like other ionophores, has shown a broad spectrum of bioactivity in a variety of cancers. However, its effects on chondrocytes remain unknown. In this study, we evaluated whether SAL could regulate dedifferentiation in chondrocytes. Our findings indicate that SAL promotes the dedifferentiation of chondrocytes through the activation of ERK kinase.
Materials and methods

Isolation and monolayer culture of rabbit articular chondrocytes
Rabbit knee articular chondrocytes were isolated from New Zealand White Rabbits (2-weeks-old, KOATECH, Pyeoungtaek, Republic of Korea). The study was approved by the Ethics Committee at the Kong-ju National University. Cartilage slices were digested with 0.2% collagenase type II for 7 h in a 37 C CO 2 incubator. Primary cell cultures were seeded at a density of 2 Â 10 4 cells/dish in a 6-well plate at 37 C, 5% CO 2 in DMEM medium supplemented with 10% fetal bovine serum, penicillin (50 unit/mL), and streptomycin (50 mg/mL). The medium was replaced every 2 days after seeding.
After 3 days, the cell cultures were treated with salinomycin (SAL; Sigma, Saint Louis, MO, USA). PD98059 (Calbiochem, San Diego, CA, USA), which was used to inhibit MEK1/2, was added 1 h prior to SAL. In some experiments, passage (P) 0 cells were cultured to P2 by plating cells at a density of 2 Â 10 4 cells/cm 2 . The differentiation status of articular chondrocytes was determined by examining the expression of type II collagen by western blot analysis, or by determining the expression of type I collagen by RT-PCR.
Western blot analysis
Whole cell lysates and chondrocyte nuclear extracts were prepared and subjected to SDS-PAGE. Proteins were extracted using a buffer containing 50 mM TriseHCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, and 0.1% SDS supplemented with protease inhibitors and phosphatase inhibitors on ice for 30 min. Cell debris was removed by centrifugation at 13,000 rpm for 10 min at 4 C. The protein concentration of the whole cell lysates was determined using a bicinchoninic acid (BCA) assay. Protein samples were boiled for 5 min in 1 Â SDS sample buffer (125 mM TriseHCl, pH 6.8, 7.5% glycerol, 2% SDS, and 0.02% bromophenol blue) containing 1% mercaptoethanol. Proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked with 5% non-fat dry milk in Tris-buffered saline for 1 h at room temperature and washed three times with Tween-Tris-buffered saline. The following antibodies were employed to detect proteins: anti-collagen type II (Santa Cruz, California, CA, USA; 1:1000 dilution), anti-pERK (Cell Signaling Technology, Beverly, MA, USA; 1:1000 dilution), and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Santa Cruz, California, CA, USA; 1:3000 dilution). The membrane was incubated with primary antibodies overnight at 4 C. The blots were developed using a peroxidaseconjugated secondary antibody (1: 3000 dilution) for 2 h at room temperature. The enhanced chemiluminescence reagent was used to identify reactive bands. Finally, the bands were quantified using the LAS4000 (Fuji Film, Tokyo, Japan).
Reverse transcriptase (RT) e PCR
Cells were plated onto 35-mm culture dishes at a density of 2 Â 10 4 . After 3 days, SAL was added to the culture medium and incubated for 24 h. Cultures were washed with cold PBS, and the cells were harvested by scraping with a rubber policeman. Cells cultured without SAL were used as a negative control. Lysates were microcentrifuged at 13,000 rpm for 10 min at 4 C, and the cell pellets were collected for mRNA extraction. Total RNA was isolated with TRIZOL reagent ( . PCR products were resolved on a 1% agarose gel and visualized with UV light after ethidium bromide staining.
Immunofluorescence staining
Cells were fixed with 3.5% paraformaldehyde in phosphatebuffered saline (PBS) for 15 min at room temperature and permeabilized with 0.1% Triton X-100 in PBS. The cells were then blocked with 5% skim milk to prevent non-specific reactions. The fixed cells were washed and incubated for 2 h with antibodies against type II collagen (1:100) and pERK. The cells were washed and incubated with secondary antibodies for 1 h, followed by washing with PBS. The fluorescence images were recorded with a BX51 fluorescence microscope (Olympus, Tokyo, Japan).
Immunohistochemical staining
Rabbit articular cartilage specimens were fixed in 4% formaldehyde, embedded in paraffin, and cross-sectioned. For immunohistological analysis of type II collagen, sections were deparaffinized in xylene and rehydrated in graded alcohol. After washing with PBS, the sections were first incubated with 3% hydrogen peroxide for 15 min. The sections were immersed in 0.1 M sodium citrate buffer (pH 7.2) and heated at 90 C in a water bath for 40 min. Next, sections were blocked with 10% fetal bovine serum for 10 min and incubated for 1 h at room temperature with a mouse anti-type II collagen antibody (1:50 dilution) as the primary antibody. The primary antibody was detected using the avidinebiotin conjugate method according to the instructions provided in the DAKO kit (Dako Cytomation, Copenhagen, Denmark). Peroxidase activity was detected using the DAKO DAB kit (Dako Cytomation). After the sections were rinsed with PBS, the nuclei were counterstained with hematoxylin. Each section was observed under a light microscope (Â100).
Alcian blue staining
The cells were fixed with 3.5% paraformaldehyde in PBS for 15 min and stained with 0.1% Alcian blue in 0.1 M HCl overnight. The chondrocytes were washed three times with PBS buffer and 6 M guanidine HCl was added for 6 h. Production of sulfated proteoglycan was measured at 595 nm. Rabbit joint cartilage explants were fixed in 4% paraformaldehyde in PBS for 24 h at 4 C, washed with PBS, dehydrated with graded ethanol, embedded in paraffin, and sectioned at 4 mm thickness. The sections were stained by standard procedures using Alcian blue.
MTT assay
Cells were plated onto a 96-well plate and treated with different concentrations of SAL for 24 h or with 5 mM SAL for the indicated time periods. The medium was removed and cells were cultured in DMEM supplemented with 0.5 mg/mL MTT. After 4 h incubation, the insoluble formazan crystals within cells were extracted by DMSO, and absorbance was measured by ELISA analyzer at wavelength of 595 nm. Wells without cells were used as blanks and were subtracted as background from each sample. Results were expressed as a percentage of control.
Flow cytometry
Chondrocytes were incubated with 5 mM SAL for 24 h. Then cells were fixed in 70% ethanol at 4 C for 1 h, washed and incubated with RNAse (50 mg/ml) and propidium iodide (PI, 100 mg/ml) for 30 min at room temperature in the dark. PI fluorescence of nuclei was measured by flow cytometry on a flow cytometer (Partec GmbH, Münster, Germany).
Data analysis and statistics
At least three independent experiments were performed in triplicate for all analyses. Data are presented as the mean ± the standard error of the mean (SEM). Results were analyzed using a one-way analysis of variance (ANOVA), and all pairwise comparisons between groups were conducted using the Turkey post hoc test; p values 0.05 were considered statistically significant.
Results
SAL reduces proliferation of rabbit articular chondrocytes. To examine the effect of SAL on proliferation, chondrocytes were treated with the different concentrations of SAL at 1, 2.5, 5, and 10 mM for 24 h or 5 mM SAL for the indicated time periods (Fig. 1) .
SAL decreased proliferation of cells in a dose-and time-dependent manner ( Fig. 1A and B) . Fig. 1C shows that SAL-induced the percentage of cells at S phase arrest during cell cycle progression. However, cells at sub-G1 phase did not alter by SAL. Our results indicated that SAL caused a decrease of cell proliferation without cell death (Fig. 1) . Therefore, all of the obtained data from alcian blue staining were corrected by the ratio of proliferation.
SAL causes dedifferentiation of rabbit articular chondrocytes. To determine whether SAL affects differentiation of chondrocytes, we examined type II collagen expression and sulfatedproteoglycan production after exposure to SAL (Fig. 2) . Western blot analysis revealed that SAL treatment led to a loss of type II collagen in a dose-and time-dependent manner (Fig. 2, A and B) . RT-PCR analysis revealed that SAL treatment suppressed type II collagen and Sox-9 expression, and induced fibroblastic type I collagen expression (Fig. 2, A and B) . Interestingly, these phenotypes are a hallmark of chondrocyte dedifferentiation. We next examined the synthesis of sulfated-proteoglycans (Fig. 2, C and D) . Alcian blue staining indicated that SAL caused a dose-and timedependent decrease in sulfated-proteoglycan synthesis (Fig. 2, C  and D) . Since the proliferation of cells were inhibited by SAL in a dose-and time-dependent manner, the value of Alcian blue staining was corrected by the ratio of proliferation (Fig. 2C and D) . These results indicate that SAL causes dedifferentiation of chondrocytes (Fig. 2) . SAL-induced dedifferentiation was regulated by the ERK pathway.
We examined whether SAL-mediated MAPK activation is associated with dedifferentiation of chondrocytes (Fig. 3) . Western blot analysis revealed that ERK is phosphorylated in a dose-and timedependent manner (Fig. 3A) following SAL treatment. Further, there is a significant increased immunoreactivity of pERK (Fig. 3B) . Interestingly SAL-induced ERK phosphorylation (Fig. 3A) and pERK nuclear translocation reached a maximum after 24 h. Further, there was no change in total ERK level was observed. These data suggest that SAL caused the phosphorylation of ERK and translocation of ERK into the nucleus (Fig. 3) .
To examine whether ERK plays a crucial role in the regulation of type II collagen, we treated cells with or without the specific inhibitor PD98059 (Fig. 4) . Treatment with PD98059 reversed the SAL-induced loss of type II collagen and Sox-9, and reduced the SAL-induced increase in type I collagen, as determined by RT-PCR (Fig. 4A) . Western blot analysis also revealed that treatment of cells with PD98059 and SAL recovered the type II collagen expression (Fig. 4B) . Alcian blue staining showed that SAL significantly reduced sulfated-proteoglycans, an effect that was completely blocked by PD98059 treatment (Fig. 4C) . Treatment of chondrocytes with PD98059 did not alter cell proliferation and apoptosis (Fig. 4D) . These results support the notion that ERK activation is sufficient to cause the dedifferentiation of chondrocytes in response to SAL (Fig. 4) .
The effect of PD98059 on type II collagen expression and sulfated-proteoglycan production in chondrocytes and cartilage was further evaluated using immunofluorescence and immunohistochemical microscopy (Fig. 5) . Double staining for type II collagen and the nucleus showed that treatment with SAL resulted in a loss of type II collagen and sulfated-proteoglycan staining. In contrast, PD98059 treatment reversed the SAL-induced suppression of type II collagen expression and sulfated-proteoglycan synthesis (Fig. 5) . Thus, these results indicate that SAL induces chondrocytes dedifferentiation through the ERK pathway (Fig. 5) .
Chondrocytes can undergo dedifferentiation upon serial monolayer culture, and display a loss of type II collagen expression and enhanced type I collagen expression. This effect can be reversed by culturing dedifferentiated cells in alginate gel (17) . Dedifferentiation caused by serial monolayer culture at P2 significantly enhanced ERK-1/2 activity, and the addition of PD98059 decreased phosphorylation levels (Fig. 6) . Treatment of dedifferentiated cells with SAL resulted in an accelerated decrease in type II collagen expression as detected by western blot analysis (Fig. 6 ). Under these conditions, RT-PCR also revealed that treatment with PD98059 inhibited SAL-induced dedifferentiation, confirming a loss of type I collagen and an increase in type II collagen expression (Fig. 6) .
SAL enhances MMP-1 and MMP-13 expression independent of the ERK pathway.
MMPs suppress the expression of cartilage-specific ECM components, such as type II collagen and prostaglandins. We therefore examined the expression of MMPs (MMP-1 and MMP-13) to assess whether they are related to SAL-induced dedifferentiation (Fig. 7) . SAL treatment increased MMP-1 and MMP-13 expression in a dosedependent manner (Fig. 7A) ; however, treatment with PD98059 did not have an effect on SAL-induced MMP-1 and MMP-13 expression (Fig. 7B) . These data indicate that SAL regulates MMPs (MMP-1 and MMP-13) independent of the ERK signaling pathway.
Discussion
SAL is widely used in veterinary medicine and has recently been shown to regulate cellular responses in various cell types (18) . The pharmacological action of SAL has generated increased attention in recent years. Recent studies have demonstrated that SAL is toxic to cancer stem cells, through its ability to deplete cellular ATP. Nevertheless, SAL is relatively non-toxic in primary cells (19) . The anticancer activity of SAL is related to oxidative stress, through the production of endogenous reactive oxygen species (ROS) that can disrupt mitochondrial function (20, 21) . In our previous studies, stress agents, such as ROS, were shown to regulate apoptosis, proliferation, differentiation, and inflammation in rabbit articular chondrocytes (22) . Furthermore, Szkudlarek-Mikyo et al., reported that SAL regulates differentiation in adipocytes (18) . However, there is a lack of data regarding the potential effects of SAL on differentiation. In the present study, we investigated the effect of SAL on chondrocyte dedifferentiation. We found that SAL could induce dedifferentiation in vitro. SAL treatment was shown to affect the expression of several proteins including Sox-9. Previous studies have shown that Sox-9 has a primary role in chondrocyte differentiation. Sox-9 plays a crucial role in the specific activation of collagen type II, and is a key transcriptional regulator of chondrocytes differentiation (23, 24) . Furthermore, SAL treatment decreased the intensity of Alcian blue staining, suggesting a decrease in the synthesis of sulfated-proteoglycan (Fig. 2) . Strikingly, however, SAL did not affect the production of intracellular ROS in chondrocytes.
Numerous signaling pathways contribute to chondrocytes dedifferentiation, including the MAPK pathway. Previous reports indicate that the ERK pathway mediates chondrocytes dedifferentiation in rabbit chondrocytes (25, 26) . In addition, p38 and JNK are known to control cell proliferation, inflammation, and differentiation (10, 23, 25, 27, 28) . Several dedifferentiation stimulating factors, such as SNP and RA, have been used to show that the activation of MAPK is needed to cause chondrocytes dedifferentiation (29e31). To investigate the involvement of the MAPK cascade during SALinduced dedifferentiation of chondrocytes, the phosphorylation pattern of the three major pathways that involve MAPK family members, ERK, p38, and JNK, were assessed by western blot after SAL treatment. Chondrocytes treated with SAL displayed enhanced ERK kinase activity, without alterations to JNK and p38 MAP kinase, suggesting that SAL can induce dedifferentiation of chondrocytes via the ERK signaling pathways. MMPs acts on a variety of ECM substrates, including degenerated collagen produced by native collagen type I, II, IV, and VX after cleavage by collagenase, aggrecan, elastin, and fibronectin (5, 32) . MMP has been shown to play a significant role in chondrocytes dedifferentiation. In OA, chondrocytes produce abnormally high levels of interstitial collagenases (MMP-1 and MMP-13), a member of the Zn 2þ -and Ca 2þ -dependent family of matrix metalloproteinases (4, 5) . In the present study, SAL-induced MMP-1 and MMP-13 expression (Fig. 7) . However, PD98059, a selective inhibitor of ERK, had no effect on SAL-induced MMP-1 and MMP-13 expression. This data collectively suggest that the ERK cascade does not play a pivotal role in the expression of MMP-1 and MMP-13 in SAL-induced dedifferentiation.
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